In AML, the core-binding factor (CBF) family member RUNX1 is involved in the recurrent chromosomal aberrations t(8;21), leading to the leukaemia-initiating RUNX1::RUNX1T1 fusion, predicting favourable prognosis [24]. This evidence concerns the gene CEBPZ and acute myeloid leukemia.